Does LEVOMILNACIPRAN Cause Off label use? 376 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 376 reports of Off label use have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 27.3% of all adverse event reports for LEVOMILNACIPRAN.
376
Reports of Off label use with LEVOMILNACIPRAN
27.3%
of all LEVOMILNACIPRAN reports
156
Deaths
121
Hospitalizations
How Dangerous Is Off label use From LEVOMILNACIPRAN?
Of the 376 reports, 156 (41.5%) resulted in death, 121 (32.2%) required hospitalization, and 98 (26.1%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 376 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOMILNACIPRAN Cause?
Drug ineffective (315)
Gastrooesophageal reflux disease (295)
Vomiting (294)
Hypoaesthesia (290)
Abdominal pain upper (285)
Paraesthesia (282)
Memory impairment (277)
Blepharospasm (276)
Taste disorder (276)
Drug intolerance (275)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which LEVOMILNACIPRAN Alternatives Have Lower Off label use Risk?
LEVOMILNACIPRAN vs LEVONORGESTREL
LEVOMILNACIPRAN vs LEVORPHANOL
LEVOMILNACIPRAN vs LEVOSIMENDAN
LEVOMILNACIPRAN vs LEVOSULPIRIDE
LEVOMILNACIPRAN vs LEVOTHYROXINE